Cargando…
The clinical and prognostic impact of aldehyde dehydrogenase 1 in non-small cell lung cancer: a meta-analysis
BACKGROUND: Aldehyde dehydrogenase 1 (ALDH1) has been identified as a cancer stem cell marker. However, the clinical role of ALDH1 in non-small cell lung cancer (NSCLC) remains conflicting. This study was conducted to investigate the correlation of ALDH1 with NSCLC patients’ clinicopathological char...
Autores principales: | Xue, Jinru, Zhao, Yan, Zou, Qingxu, Liang, Feihai, Lin, Fengwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797672/ https://www.ncbi.nlm.nih.gov/pubmed/35117538 http://dx.doi.org/10.21037/tcr.2020.02.09 |
Ejemplares similares
-
CtBP1 promotes tumour‐associated macrophage infiltration and progression in non–small‐cell lung cancer
por: Wang, Zhenxing, et al.
Publicado: (2020) -
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer
por: Zhou, Lei, et al.
Publicado: (2016) -
Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer
por: Ma, Yu-mei, et al.
Publicado: (2016) -
Targeting aldehyde dehydrogenase for prostate cancer therapies
por: Ma, Miao, et al.
Publicado: (2022) -
Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms
por: Orywal, Karolina, et al.
Publicado: (2016)